DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xs2rx9/global_urinary) has announced the addition of the "Global Urinary Incontinence Pipeline Capsule - 2013" report to their offering.
Fore Pharma's latest report Global Urinary Incontinence Pipeline Capsule - 2013' provides up-to-date information on key Research and Development (R&D) activities in the global urinary incontinence market. It covers active urinary incontinence pipeline molecules in clinical trials, preclinical research, and drug discovery.
This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
The scope of the report includes information on urinary incontinence pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World). Urinary incontinence pipeline molecules licensing activities are also covered in this report.
Key Features of the Report:
- Urinary incontinence Pipeline Overview
- Urinary incontinence Phase 3 Clinical Trial Pipeline
- Urinary incontinence Phase 2 Clinical Trial Pipeline
- Urinary incontinence Phase 1 Clinical Trial Pipeline
- Urinary incontinence Preclinical Research Pipeline
- Urinary incontinence Drug Discovery Stage Pipeline
- Urinary incontinence Pipeline in the U.S.
- Urinary incontinence Pipeline in Europe
- Licensing Activities in Global Urinary Incontinence Market
For more information visit http://www.researchandmarkets.com/research/xs2rx9/global_urinary
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
